Guangdong Hengrui Pharmaceutical Co., Ltd

This early-stage study tested a new injection called SHR-1139 to see if it's safe for people. Researchers gave single doses to healthy volunteers and multiple doses to patients with moderate-to-severe plaque psoriasis. The main goal was to check for side effects and see how the d…

This early-stage study tested the safety of a new inhaled drug called SHR-4597. It involved 62 healthy volunteers and people with asthma to see how their bodies handled single and multiple doses. The main goal was to check for side effects and understand how the drug moves throug…

This early-stage study tested a new injectable drug called SHR-2173 in 30 adults with lupus. The main goal was to check if the drug is safe and how the body processes it. Researchers gave multiple injections under the skin to understand side effects and how the drug behaves in pe…

This study tested a single injection of an investigational drug called SHR-1905 in teenagers with asthma. The main goals were to see how the drug moves through the body, if it is safe, and to get an early look at whether it might help control asthma. Nine participants received th…

This study tested whether a new drug called HRS-2261 could safely reduce the severity of a long-term, unexplained cough. About 100 adults with this condition for over a year took either the drug or a placebo for four weeks. Researchers measured changes in cough severity and quali…